MARKET

AVXL

AVXL

Anavex Life Scie
NASDAQ
4.650
0.000
0.00%
After Hours: 4.660 +0.01 +0.22% 19:57 03/13 EDT
OPEN
4.710
PREV CLOSE
4.650
HIGH
4.870
LOW
4.635
VOLUME
989.41K
TURNOVER
--
52 WEEK HIGH
13.99
52 WEEK LOW
2.860
MARKET CAP
430.92M
P/E (TTM)
-10.0022
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AVXL last week (0302-0306)?
Weekly Report · 6d ago
Evaluating Alzheimer's Disease Treatments
Seeking Alpha · 03/04 10:33
Anavex Life Sciences CEO Christopher Missling to Present at Citizens Life Sciences Conference
Reuters · 03/03 12:31
Weekly Report: what happened at AVXL last week (0223-0227)?
Weekly Report · 03/02 10:08
Anavex Adds Veteran Healthcare Leader to Board of Directors
TipRanks · 02/25 11:32
Anavex Life Sciences Names Dr. Axel Paeger to Board of Directors
Reuters · 02/25 11:07
Anavex Life Sciences CEO Christopher U Missling to Present at TD Cowen Annual Health Care Conference
Reuters · 02/25 07:39
Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference
Barchart · 02/25 06:30
More
About AVXL
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with high unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which it uses in the analysis of its clinical trials. Its focus is on developing treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other CNS disorders. It has two core programs and two seed programs. ANAVEX 2-73 is being developed as an oral liquid once-daily formulation for rare diseases such as Rett syndrome as well as an oral once-daily capsule formulation for diseases such as Alzheimer’s disease. ANAVEX 3-71 is a CNS-penetrable potential disease-modifying treatment for cognitive impairments. Its other candidates include ANAVEX 1-41, ANAVEX 1066 and ANAVEX 1037.

Webull offers Anavex Life Sciences Corp stock information, including NASDAQ: AVXL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVXL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVXL stock methods without spending real money on the virtual paper trading platform.